Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells

Adrià Cañellas‐Socias(Institute for Research in Biomedicine), Carme Cortina(Institute for Research in Biomedicine), Xavier Hernando‐Momblona(Institute for Research in Biomedicine), Sergio Palomo‐Ponce(Institute for Research in Biomedicine), Eoghan J. Mulholland(Centre for Human Genetics), Gemma Turón(Institute for Research in Biomedicine), Lídia Mateo(Institute for Research in Biomedicine), Sefora Conti(Institute for Bioengineering of Catalonia), Olga Roman(Institute for Research in Biomedicine), Marta Sevillano(Institute for Research in Biomedicine), Felipe Slebe(Institute for Research in Biomedicine), Diana Stork(Institute for Research in Biomedicine), Adrià Caballé(Institute for Research in Biomedicine), Antonio Berenguer(Institute for Research in Biomedicine), Adrián Álvarez-Varela(Institute for Research in Biomedicine), Nicola Fenderico(Institute for Research in Biomedicine), Laura Novellasdemunt(Institute for Research in Biomedicine), Laura Jiménez-Gracia(Centre for Genomic Regulation), Tamara Sipka(Institute for Research in Biomedicine), Lídia Bardia(Institute for Research in Biomedicine), Patricia Lorden(Centre for Genomic Regulation), Julien Colombelli(Institute for Research in Biomedicine), Holger Heyn(Universitat Pompeu Fabra), Xavier Trepat(Institució Catalana de Recerca i Estudis Avançats), Sabine Tejpar(KU Leuven), Elena Sancho(Institute for Research in Biomedicine), Daniele V. F. Tauriello(Radboud University Nijmegen), Simon J. Leedham(Centre for Human Genetics), Camille Stephan‐Otto Attolini(Institute for Research in Biomedicine), Eduard Batlle(Institució Catalana de Recerca i Estudis Avançats)
Nature
November 9, 2022
Cited by 229Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis